12 research outputs found
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD. (c) 2018 The Author(s). Published by Elsevier Masson SAS.Peer reviewe
Skills training groups for men with ADHD in compulsory care due to substance use disorder: a feasibility study
Dialectical behavior therapy (DBT)-based skills training has been developed and previously evaluated for adults with ADHD in a psychiatric outpatient context. The aim of the present study was to evaluate the feasibility of DBT-based skills training as a voluntary intervention for men with ADHD in compulsory care due to severe substance abuse. Forty sufficiently detoxified men with ADHD in compulsory care due to life-threatening substance use disorder (SUD) were included in DBT-based skills training groups. Self- and staff-rating scales were administered before and after the treatment. The refusal rate was 42.9 %. Of those who started the DBT-based skills training, 70 % completed the treatment (attendance at =75 % of the sessions). The treatment acceptability was good. Both ADHD and psychiatric symptoms decreased from pre- to post-intervention in self-ratings, but not in staff ratings. The patients reported improved general well-being. The correlation between self- and staff ratings was poor. Motivation for voluntary nonpharmacological treatment was low in a compulsory care context. However, the results indicate that a DBT-based skills training program for adults with ADHD may be feasible for some patients with ADHD in combination with SUD in compulsory care, provided that considerable resources are allocated with adjustments to the target group and compulsory care context
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Background Attention-deficit/hyperactivity disorder (ADHD) is among the
most common psychiatric disorders of childhood that often persists into
adulthood and old age. Yet ADHD is currently underdiagnosed and
undertreated in many European countries, leading to chronicity of
symptoms and impairment, due to lack of, or ineffective treatment, and
higher costs of illness.
Methods The European Network Adult ADHD and the Section for
Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European
Psychiatric Association (EPA), aim to increase awareness and knowledge
of adult ADHD in and outside Europe. This Updated European Consensus
Statement aims to support clinicians with research evidence and clinical
experience from 63 experts of European and other countries in which ADHD
in adults is recognized and treated.
Results Besides reviewing the latest research on prevalence,
persistence, genetics and neurobiology of ADHD, three major questions
are addressed: (1) What is the clinical picture of ADHD in adults? (2)
How should ADHD be properly diagnosed in adults? (3) How should adult
ADHDbe effectively treated?
Conclusions ADHD often presents as a lifelong impairing condition. The
stigma surrounding ADHD, mainly due to lack of knowledge, increases the
suffering of patients. Education on the lifespan perspective, diagnostic
assessment, and treatment of ADHD must increase for students of general
and mental health, and for psychiatry professionals. Instruments for
screening and diagnosis of ADHD in adults are available, as are
effective evidence-based treatments for ADHD and its negative outcomes.
More research is needed on gender differences, and in older adults with
ADHD. (c) 2018 The Author(s). Published by Elsevier Masson SAS